Valuation : Medpace Holdings, Inc.

Market Cap 17.28B 14.83B 13.92B 12.71B 23.99B 1,648B 24.11B 165B 63.84B 831B 64.88B 63.47B 2,754B P/E 2026 *
35.2x
P/E 2027 * 32.3x
Enterprise Value 16.48B 14.14B 13.27B 12.12B 22.88B 1,571B 22.99B 157B 60.88B 793B 61.86B 60.52B 2,626B EV / Sales 2026 *
5.78x
EV / Sales 2027 * 5.29x
Free-Float
80.26%
Yield 2026 *
-
Yield 2027 * -
1 day+0.81%
1 week+1.77%
Current month+7.27%
1 month+2.94%
3 months+44.26%
6 months+38.46%
Current year+10.22%
1 week 600.01
Extreme 600.01
629.69
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
20/08/26 Fiscal year

Chief Financial Officer

10,200 0.0365%
20/08/26 Sell

Chief Executive Officer

-27,174 0.0974%
19/08/26 Sell

Director

-5,000 0.0179%
Change 5-day change 1-year change 3-year change Capi.($)
+0.81%+1.77%+31.91%+138.26% 17.28B
-0.05%-0.24%+2.10%+22.90% 50.96B
+1.92%+0.36%+477.97%+550.09% 46.18B
-0.15%-0.28%+21.65%+89.41% 42.73B
+0.81%+4.91%+39.28%+19.41% 43.04B
-2.27%-3.02%+14.22%+51.50% 33.48B
-1.08%-3.61% - - 16.43B
-0.14%-0.19%+11.54%+28.32% 14.73B
-0.85%+1.76%+80.26%+47.26% 14.09B
+0.01%-2.06%-1.65%-34.09% 13.03B
Average -0.35%+0.99%+75.25%+101.45% 29.2B
Weighted average by Cap. -0.31%+1.02%+98.36%+130.57%

Financials

2026 *2027 *
Net sales 2.85B 2.45B 2.3B 2.1B 3.96B 272B 3.98B 27.19B 10.54B 137B 10.71B 10.48B 454B 3.03B 2.6B 2.44B 2.23B 4.2B 289B 4.22B 28.86B 11.18B 146B 11.37B 11.12B 482B
Net income 503M 431M 405M 370M 698M 47.93B 701M 4.79B 1.86B 24.18B 1.89B 1.85B 80.09B 547M 469M 440M 402M 759M 52.13B 763M 5.21B 2.02B 26.3B 2.05B 2.01B 87.11B
Net Debt -802M -689M -646M -590M -1.11B -76.52B -1.12B -7.65B -2.96B -38.6B -3.01B -2.95B -128B -1.25B -1.07B -1.01B -921M -1.74B -119B -1.75B -11.94B -4.63B -60.25B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
26/08/26 $619.05 +0.81% 149,419
25/08/26 $614.06 -0.96% 247,113
24/08/26 $620.03 -0.12% 186,216
21/08/26 $620.75 +1.32% 225,882
20/08/26 $612.64 +0.72% 254,525
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
619.05USD
Average target price
581.83USD
Spread / Average Target
-6.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock